Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1315-1320

  Pook, Sim Hwee ^a   Rahmat, Juwita Norasmara Bte ^a   Esuvaranathan, Kesavan ^a   Mahendran, Ratha ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bacillus Calmette Guerin; Bladder cancer cells; Focal adhesion kinase; Integrins

Indexed keywords

BCG VACCINE; CD51 ANTIGEN; FOCAL ADHESION KINASE;

ARTICLE; BLADDER TUMOR; CELL CULTURE; CYTOTOXICITY; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; MYCOBACTERIUM BOVIS; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHOSPHORYLATION; PHYSIOLOGY; TRANSITIONAL CELL CARCINOMA;

BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CYTOTOXICITY, IMMUNOLOGIC; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTEGRIN ALPHAV; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS; PHOSPHORYLATION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 38449118811     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1315     Document Type: Article

References (21)

1. Netto Junior NR, Levi d'Ancona CA, Claro JF and Ilari O: Immunoprophylaxis of superficial bladder cancer: a prospective and randomized comparison of oral versus intravesical Bacillus Calmette-Guerin. Arch Esp Urol 44: 1025-1028, 1991.
2. Ratliff TL, Kavoussi LR and Catalona WJ: Role of fibronectin in intravesical BCG therapy for superficial bladder cancer. J Urol 139: 410-414, 1998.
3. Ratliff TL, Palmer JO, McGarr JA and Brown EJ: Intravesical Bacillus Calmette-Guerin therapy for murine bladder tumor: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin. Cancer Res 47: 1762-1766, 1987. (Pubitemid 17056672)
4. Zhao W, Schorey JS, Bong-Mastek M, Ritchey J, Brown EJ and Ratliff TL: Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity. Int J Cancer 86: 83-88, 2000. (Pubitemid 30133991)
5. Zhang Y, Khoo HE and Esuvaranathan K: Effects of Bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro. Int J Cancer 71: 851-857, 1997. (Pubitemid 27237209)
6. Bevers RFM, de Boer EC, Kurth K-H and Schamhart DHJ: BCG-induced Interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines. Eur Cytokine Netw 9: 181-186, 1998. (Pubitemid 28301577)
7. Ikeda N, Toida I, Iwasaki A, Kawai K and Akaza H: Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): a role of BCG internalization into tumor cells. Int J Urol 9: 29-35, 2002. (Pubitemid 34309964)
8. Pook SH, Esuvaranathan K and Mahendran R: N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells. J Urol 68: 780-785, 2002. (Pubitemid 34793362)
9. de Boer EC, Bevers RF, Kurth KH and Schamhart DH: Double fluorescent flow cytometric assessment of bacterial internalization and binding by epithelial cells. Cytometry 25: 381-387, 1996. (Pubitemid 26418494)
10. Luo Y, Chen X and O'Donnell MA: Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect. Cytokine 21: 17-26, 2003. (Pubitemid 36369372)
11. Kurisu H, Matsuyama H, Shimabukuro T and Naito K: Cytokine-mediated antitumor effect of bacillus Calmette-Guerin on tumor cells in vitro. Cancer Immunol Immunother 34: 249-253, 1994. (Pubitemid 24316766)
12. Jackson AM, Alexandroff AB, McIntyre M, Esuvaranathan K, James K and Chisholm GD: Induction of ICAM 1 expression on bladder tumors by BCG immunotherapy. J Clin Pathol 47: 309-312, 1994. (Pubitemid 24171696)
13. Prescott S, James K, Busuttil A, Hargreave TB, Chisholm GD and Smyth JF: HLA-DR expression by high-grade superficial bladder cancer treated with BCG. Br J Urol 63: 264-269, 1989. (Pubitemid 19084473)
14. Chen F, Zhang G, Iwamoto Y and See WA: Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking α5β1 integrin. J Urol 170: 605-610, 2003. (Pubitemid 36870269)
15. Chen FH, Crist SA and Zhang GJ: Interleukin-6 production by human bladder tumor cell lines is up-regulated by BCG through NF-κB and AP-1 via an immediate early pathway. J Urol 168: 786-797, 2002. (Pubitemid 34793363)
16. Hudson MA, Brown EJ, Ritchey JK and Ratliff TL: Modulation of fibronectin-mediated Bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways. Cancer Res 51: 3726-3732, 1991.
17. Schorey JS, Holsti MA, Ratliff TL, Allen PM and Brown EJ: Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol Microbiol 21: 321-329, 1996. (Pubitemid 26291538)
18. Barker RN, Erwig LP, Hill KS, Devine A, Pearce WP and Rees AJ: Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic cells. Clin Exp Immunol 127: 220-225, 2002. (Pubitemid 34233926)
19. Persson C, Carballeira N, Wolf-Watz H and Fallman M: The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, the associated accumulation of theses proteins in peripheral focus adhesions. EMBO J 16: 2307-2318, 1997. (Pubitemid 27258632)
20. Raynaud C, Etiene G, Peyron P, Laneele MA and Daffé M: Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis. Microbiology 144: 577-587, 1998. (Pubitemid 28067763)
21. Koul A, Choidas A, Treder M, Tyagi AK, Drlica K, Singh Y and Ullrich A: Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J Bacteriol 182: 5425-5432, 2000.